"The growing awareness of Cryosite’s technical and regulatory expertise, sound management and financial stability has enabled us to attract many blue chip clients including Pfizer, Bristol-Myers, Amgen, Schering-Plough, Johnson & Johnson Research.
Cryosite is now the largest clinical trials logistics provider in Australia and currently supports over 350 different trials for 40 local and international companies.
Peter MacCallum Cancer Institute is the only hospital in Australia dedicated to the management of cancer patients and is one of the world’s largest organisations dedicated to cancer treatment and research. Cryosite provide “Peter Macs” patient’s with safe cryogenic storage of their adult stem cells when in cancer remission for latter use if they suffer a relapse and require the re-infusion of their own cells."
CTE Price at posting:
47.0¢ Sentiment: Buy Disclosure: Held